Insider Transactions in Q2 2024 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Kevin Bitterman |
BUY
Open market or private purchase
|
Indirect |
222,223
+34.57%
|
$8,000,028
$36.0 P/Share
|
|
Jun 17
2024
|
Mona Ashiya Director |
BUY
Open market or private purchase
|
Indirect |
83,334
+4.46%
|
$3,000,024
$36.0 P/Share
|
|
Jun 17
2024
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
83,334
+4.46%
|
$3,000,024
$36.0 P/Share
|
|
Jun 17
2024
|
Ai Dmi LLC |
BUY
Grant, award, or other acquisition
|
Direct |
416,667
+10.48%
|
$15,000,012
$36.0 P/Share
|
|
Jun 03
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
1,957
-66.78%
|
$68,495
$35.99 P/Share
|
|
Jun 03
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
1,957
+29.66%
|
$11,742
$6.26 P/Share
|
|
May 01
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
201
-90.3%
|
$5,628
$28.82 P/Share
|
|
May 01
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+50.0%
|
$1,809
$9.86 P/Share
|
|
Apr 11
2024
|
William Richard White |
SELL
Open market or private sale
|
Direct |
2,560
-98.48%
|
$79,360
$31.99 P/Share
|
|
Apr 11
2024
|
William Richard White |
BUY
Exercise of conversion of derivative security
|
Direct |
2,560
+36.95%
|
$15,360
$6.26 P/Share
|
|
Apr 10
2024
|
William Jacob Savage Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,870
+33.5%
|
$43,740
$2.65 P/Share
|